The ONCO/Reveal Lung cfDNA Panel is a targeted circulating free DNA (cfDNA)-based liquid biopsy solution for the sensitive detection of resistance or driver mutations from plasma samples. There is currently a large interest in using circulating tumor DNA detection in the bloodstream for treatment monitoring, for treatment sensitivity, as well as for its potential use for early detection.
- Streamlined single-well processing approach
- High on-target rate
- Targets 17 known lung cancer oncogenes